C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies

Mahtab Mashayekhi; Jonathan E. Zuckerman; Jonathan Barratt; Richard J. Glassock; Fernando Caravaca-Fontán; Raymond K. Hsu; Arun Rajasekaran; Edgar Lerma; Sahibzadi Mahrukh Noor; Amir Abdipour; Sayna Norouzi

doi:10.1016/j.xkme.2026.101258

C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies

Mahtab Mashayekhi
, Jonathan E. Zuckerman
, Jonathan Barratt
, Richard J. Glassock
, Fernando Caravaca-Fontán
, Raymond K. Hsu
, Arun Rajasekaran
, Edgar Lerma
, Sahibzadi Mahrukh Noor
, Amir Abdipour
, Sayna Norouzi

Medicine

Research output: Contribution to journal › Review article › peer-review

Original language	English
Article number	101258
Journal	Kidney Medicine
Volume	8
Issue number	3
DOIs	https://doi.org/10.1016/j.xkme.2026.101258
State	Published - Mar 2026

ASJC Scopus Subject Areas

Internal Medicine
Nephrology

Keywords

C3 glomerulonephritis
C3 glomerulopathy
complement inhibitors
dense deposit disease

Access to Document

10.1016/j.xkme.2026.101258

OpenUrl availability

Full text

Cite this

@article{c387801b10cb43f9909969dc8614b5dc,

title = "C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies",

keywords = "C3 glomerulonephritis, C3 glomerulopathy, complement inhibitors, dense deposit disease",

author = "Mahtab Mashayekhi and Zuckerman, \{Jonathan E.\} and Jonathan Barratt and Glassock, \{Richard J.\} and Fernando Caravaca-Font{\'a}n and Hsu, \{Raymond K.\} and Arun Rajasekaran and Edgar Lerma and Noor, \{Sahibzadi Mahrukh\} and Amir Abdipour and Sayna Norouzi",

note = "Publisher Copyright: {\textcopyright} 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is an open access article under the CC BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0/",

year = "2026",

month = mar,

doi = "10.1016/j.xkme.2026.101258",

language = "English",

volume = "8",

journal = "Kidney Medicine",

issn = "2590-0595",

number = "3",

}

TY - JOUR

T1 - C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies

AU - Mashayekhi, Mahtab

AU - Zuckerman, Jonathan E.

AU - Barratt, Jonathan

AU - Glassock, Richard J.

AU - Caravaca-Fontán, Fernando

AU - Hsu, Raymond K.

AU - Rajasekaran, Arun

AU - Lerma, Edgar

AU - Noor, Sahibzadi Mahrukh

AU - Abdipour, Amir

AU - Norouzi, Sayna

N1 - Publisher Copyright: © 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is an open access article under the CC BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0/

PY - 2026/3

Y1 - 2026/3

KW - C3 glomerulonephritis

KW - C3 glomerulopathy

KW - complement inhibitors

KW - dense deposit disease

UR - https://www.scopus.com/pages/publications/105034468151

UR - https://www.scopus.com/pages/publications/105034468151#tab=citedBy

U2 - 10.1016/j.xkme.2026.101258

DO - 10.1016/j.xkme.2026.101258

M3 - Review article

C2 - 41783430

AN - SCOPUS:105034468151

SN - 2590-0595

VL - 8

JO - Kidney Medicine

JF - Kidney Medicine

IS - 3

M1 - 101258

ER -

C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this